Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Lupin Gets FDA Approval For Risperidone Long-Acting Injectable With CGT Exclusivity
Global pharmaceutical company Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Risperidone extended-release injectable suspension. The approval covers three different dosage levels: 25 mg, 37.5 mg, and 50 mg per vial, all in single-dose formats. This is the first time Lupin has received approval using the proprietary technology developed by its subsidiary, Nanomi B.V. The product has also been granted 180 days of Competitive Generic Therapy (CGT) exclusivity. Nanomi is a division of Lupin that focuses on researching and developing long-acting injectable medicines, aimed at improving clinical results.
Hoth Submits EMA App for HT-001 Phase II Cancer Trial
Hoth Therapeutics, Inc, a biopharmaceutical company focused on creating new treatments, has submitted a Clinical Trial Application (CTA) to the European Medicines Agency (EMA) as part of its plan to expand the Phase II study of HT-001. This experimental topical treatment is meant to help with skin side effects that often happen when patients use Epidermal Growth Factor Receptor inhibitors (EGFRi), which are commonly used in cancer treatments.
Oracle Launches AI Hub to Boost Healthcare Efficiency
At the Oracle | Cloud Applications and Cloud Platform and Life Sciences Summit, Oracle Health launched the Oracle AI Center of Excellence for Healthcare. This new effort is meant to help healthcare organizations keep up with the fast-growing field of artificial intelligence. The center offers a central place for resources, tools, and expert advice to assist hospitals and health systems in using AI across different parts of their operations. Oracle is working with partners throughout the healthcare industry to help these organizations find new ways to improve patient care, make operations more efficient, and achieve better financial results through advanced AI technology.
IQVIA Launches Next-Gen Clinical Trial Financial Suite
IQVIA, a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced the launch of its Clinical Trial Financial Suite (CTFS), an AI-enabled platform orchestrating all financial aspects of clinical trials. CTFS is designed to eliminate inefficiencies created by siloed systems and fragmented processes. In contrast to other industry offerings, CTFS unifies budgeting, contracting, forecasting and payment workflows with shared data and end-to-end processes.
GE Healthcare to Acquire Icometrix for Brain MRI Solutions
GE HealthCare announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as Alzheimer’s disease to meet the growing demand for MRI in personalized treatment planning.
To share your insights, please write to us at sudipto@intentamplify.com
